Videos

What Investors Need to Know About Biotech ETF Investing

Despite concerns over a bubble and regulation, biotech investing remains very hot for investors. It doesn’t hurt that even with the recent sell-off the space is easily outperforming broad indexes so far in 2015. But with added risks, it might be time for investors to consider an ETF approach to the space so that one company doesn’t blow up a portfolio.

Eric Dutram takes a look at the biotech ETF space and some of the key differences between the most popular funds in the space in this video. He also highlights a few factors that investors must consider when they are deciding which ETF is the best for their biotech investing needs.

SPDR SP Biotech ETF: http://www.zacks.com/funds/etf/XBI/profile?cid=cs-youtube-ft-card
iShares NASDAQ Biotechnology Index Fund: http://www.zacks.com/funds/etf/IBB/profile?cid=cs-youtube-ft-card
Market Vectors Biotech ETF: http://www.zacks.com/funds/etf/BBH/profile?cid=cs-youtube-ft-card
Bioshares Biotechnology Clinical Trials: http://www.zacks.com/funds/etf/BBC/profile?cid=cs-youtube-ft-card
Bioshares Biotechnology Products Fund: http://www.zacks.com/funds/etf/BBP/profile?cid=cs-youtube-ft-card

Follow us on StockTwits: http://stocktwits.com/ZacksResearch
Follow us on Twitter: https://twitter.com/ZacksResearch
Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Articles You May Like

7 Top-Rated Stocks That Also Pay Monthly Dividends: March 2024
JOBY Stock Analysis: This Flying Car Company Could Be Worth a Gamble in 2024
7 Lithium Stocks Ready for a Major Comeback
Apple’s Antitrust Armageddon: Why the DOJ Lawsuit Is a Game-Changer for AAPL Stock
Activist Oasis may turn to a preferred playbook to help build value at Greencore